OncoSurgery - Σπηλιώτης Ιωάννης - ΚΟΣΤΟΣ ΩΦΕΛΕΙΑ ΑΠΟ ΤΗΝ ΕΦΑΡΜΟΓΗ ΤΗΣ HIPEC ΣΤΗΝ ΠΕΡΙΤΟΝΑΪΚΗ ΚΑΚΟΗΘΕΙΑ Ολοκληρώθηκε πριν 1 μήνα η αναλυτική καταγραφή των δεδομένων μιας 15ετίας και 658 περιστατικών με περιτοναϊκή κακοήθεια,
Short-term outcomes of patients undergoing HPB procedures as part of... | Download Scientific Diagram
Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy ( HIPEC) | Semantic Scholar
hipec - YouTube
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
Ioannis D. Kyriazanos - Clinical Oncology Journal (ISSN 2766-9882)
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Survival results in 49 patients after HIPEC (hyperthermic... | Download Scientific Diagram
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Overall survival of 101 patients undergoing CRS/HIPEC for peritoneal... | Download Scientific Diagram
Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). | Semantic Scholar
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Faculty
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Surgical Oncology | Rutgers Cancer Institute of New Jersey
hipec - YouTube
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Complications after CRS and HIPEC | Download Table
Liver metastasectomy-cytoreductive surgery- hyperthermic intraperitoneal chemotherapy and ileal pouch-anal anastomosis: A case report - ScienceDirect
